|
|
42
|
|
|
A231BP
|
|
|
NEURONTIN 300MG CAP (PFI) GABAPENTIN
|
|
|
GABAPENTIN
|
|
|
NEURONTIN
|
|
|
100'S
|
|
|
C
|
|
|
151.44
|
|
|
1.51
|
|
|
300MG
|
|
|
CAP
|
|
|
180
|
|
|
BLIS
|
|
|
PFI
|
|
|
PFIZER CORPORATION
|
|
|
COL
|
|
|
AVENTA BARBADOS
|
|
|
B
|
|
|
Anti-Epileptic
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|